The standard starting dose is 0.5mg once weekly, with increases every four weeks following a structured schedule
The glucagon component unique to retatrutide may affect peripheral nerve function directly or indirectly
By combining all three receptor targets, Retatrutide allows researchers to study the convergence of incretin biology and glucagon-driven energy expenditure in a single compound, opening research questions that cannot be addressed with any dual or single-receptor agonist
Shes thorough, shes easy to talk to, and shell keep you on track
4.3 Dual GIP/GLP-1 receptor agonists The unimolecular dual incretin receptor agonist offers a more physiological approach to managing diseases associated with T2DM compared to GLP-1RAs alone
It can also lower blood sugar, blood lipids, weight, and cardiovascular risk (62)